Search Results
May 12, 2026, 11:22 ET L'ORÉAL LUXE AND DATALAND REVEAL EXCLUSIVE PARTNERSHIP TO CREATE GROUNDBREAKING OLFACTORY ART EXPERIENCE
portfolio of 30 iconic brands and 30,000 luxury experts, L'Oréal Luxe is the undisputed leader of luxury beauty, ensuring each brand preserves its unique DNA while accelerating growth.Communication L'Oréal LuxeMickael Roux, [email protected]
More news about: L'Oréal Luxe
May 12, 2026, 10:30 ET The $59B Quiet Shift Reshaping How Patients Access Care
VPTDF), Hims & Hers Health (NYSE: HIMS), Novo Nordisk (NYSE: NVO), MannKind (NASDAQ: MNKD), and Ginkgo Bioworks (NYSE: DNA).
More news about: Equity Insider
May 12, 2026, 10:00 ET Cizzle Bio CEO Bill Behnke Participates in National Oncology Commercialization Panel at City of Hope's 25th Ci4CC Summit
Malkas, PhD, who serves as dean of Translational Science and External Affairs at City of Hope and is internationally recognized for her research on DNA replication, cancer cell biology, and translational therapeutics.Additional panelists included Larry Kwak, MD, PhD, who serves as CEO and chief
More news about: Cizzle Bio
May 12, 2026, 10:00 ET Maveric Systems announces strategic brand positioning focused on Engineering Trust in AI-First Banking
onboarding, real-time decisioning, reduced cost-to-serve, improved fraud detection, and accelerated modernization.Deep Banking DNA: With over 25 years of exclusive focus on banking and financial services, Maveric builds AI within the fabric of banking, not on top of it. This domain
More news about: Maveric Systems
May 12, 2026, 09:00 ET Caravel Bio Accelerates Cost‑Efficient Carbon Capture with Novel Protein Engineering
$7.8 million grant from the National Science Foundation, recognizing its ability to deliver first-in-class products across DNA synthesis, animal health, and non-pollutive chemical manufacturing.Caravel's platform unifies the traditionally fragmented protein discovery and
More news about: Caravel Bio
May 12, 2026, 09:00 ET TrilliumBiO and Oncobit Launch Advanced Uveal Melanoma Monitoring Solution in the U.S.
Oncobit's proprietary platform for personalized cancer monitoring to physicians nationwide, enabling real‑time, quantitative assessment of circulating tumor DNA (ctDNA) from a simple blood draw. Designed to complement conventional imaging approaches, the assay provides precise insights into disease dynamics,
More news about: TrilliumBiO
May 12, 2026, 09:00 ET TrilliumBiO and Oncobit Launch Advanced Uveal Melanoma Monitoring Solution in the U.S.
Oncobit's proprietary platform for personalized cancer monitoring to physicians nationwide, enabling real‑time, quantitative assessment of circulating tumor DNA (ctDNA) from a simple blood draw. Designed to complement conventional imaging approaches, the assay provides precise insights into disease dynamics,
More news about: TrilliumBiO
May 12, 2026, 07:01 ET Acurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update
announced that the USPTO granted a new patent for our DNA pol IIIC inhibitors covering composition of matter and method of use. This patent extends to December 2039, subject to extension under US patent rules. This adds to our extensive patent estate for our DNA pol IIIC inhibitors going out in some cases to
More news about: Acurx Pharmaceuticals, Inc.
May 12, 2026, 02:59 ET DNA 'barcodes' help NUS researchers pinpoint gold nanoparticles that can strike cancer at its power source
Prof Tay. "Harnessing DNA barcodes enables us to track many nanoparticle designs simultaneously in living systems and quickly identify which ones can jump through various biological hoops successfully."In the study, each gold nanoparticle formulation was tagged with a unique DNA sequence, allowing
More news about: National University of Singapore
May 12, 2026, 01:30 ET Maveric Systems announces strategic brand positioning focused on Engineering Trust in AI-First Banking
faster customer onboarding, real-time decisioning, reduced cost-to-serve, improved fraud detection, and accelerated modernization.Deep Banking DNA: With over 25 years of exclusive focus on banking and financial services, Maveric builds AI within the fabric of banking, not on top of it. This domain
More news about: Maveric Systems
May 11, 2026, 13:53 ET Legacy Launches $1M Study Advancing At-Home Semen Collection for Assisted Reproduction Technology
and IUI. The Sperm Study is designed to close those gaps.This multi-phase study will evaluate key sperm quality parameters including motility, DNA fragmentation, and post-thaw viability, while also validating the use of computer-aided semen analysis (CASA) as an alternative to basic manual semen
More news about: Give Legacy, Inc.
May 11, 2026, 13:41 ET New AI tool predicts how cells choose their future, helping uncover hidden drivers of development
genes activates or suppresses another, pushing a cell down one path instead of another. That matters because every cell in the body starts with the same DNA. What makes a skin cell different from a neuron or a muscle cell is not the genome itself, but which genes are turned on, when they are activated, and
More news about: Stowers Institute for Medical Research
May 11, 2026, 13:33 ET DNA Synthesis Market to Reach $30.4 billion, Globally, by 2035 at 18.2% CAGR: Allied Market Research
for GMP-grade synthetic DNA with high accuracy and scalability. Furthermore, the emergence of personalized gene therapies tailored to patient-specific mutations is expected to create demand for highly customized, small-batch DNA synthesis services. This shift is encouraging DNA synthesis providers to
More news about: Allied Market Research
May 11, 2026, 12:41 ET DNA Polymerase Market to Reach USD 725.8 Million by 2035 as Molecular Diagnostics and High-Fidelity Enzymes Accelerate Precision Genomics
CorporationRelated ReportsDNA/RNA Extraction Market: https://www.futuremarketinsights.com/reports/dna-rna-extraction-marketDNA Diagnostics Market:
More news about: Future Market Insights
May 11, 2026, 12:39 ET VWCO lança campanha institucional "Piensa en Grande" para mercados internacionais
Mais do que uma campanha publicitária, "Piensa en Grande" nasce como uma plataforma de comunicação que traduz o DNA da Volkswagen Caminhões e Ônibus. O conceito vai além da robustez reconhecida dos produtos e incorpora uma forma de pensar o transporte: com visão de
More news about: Volkswagen Caminhões e Ônibus
May 11, 2026, 09:57 ET Bridgestone Chosen as Exclusive Tire Partner for Historic Lamborghini Fenomeno Roadster
"Through deep collaboration, our partnership with Bridgestone delivers bespoke solutions that fully express each vehicle's character and the Lamborghini DNA. The Fenomeno Roadster is the latest example of how we continue to push boundaries together."The Fenomeno Roadster marks the latest in a long
More news about: Bridgestone Americas, Inc.
May 11, 2026, 08:36 ET Curefundr Launches First Crowdfunding Platform Dedicated to Cancer Research
pioneering DNA studies—and track progress in real-time. This model ensures that high-impact scientific ideas are no longer abandoned due to financial barriers.About
More news about: Curefundr
May 11, 2026, 08:00 ET HydroGene to present non-viral DNA delivery in non-human primates demonstrating expression and durability comparable to commercial AAV products at ASGCT 2026
A final poster presentation will highlight a novel platform that HydroGene has developed for site-specific insertion of DNA into the liver through hydrodynamic delivery of naked DNA and Cas9 ribonucleoprotein. The platform yielded therapeutic expression for hemophilia and tyrosinemia models in mice, respectively.With
More news about: HydroGene Therapeutics
May 11, 2026, 08:00 ET Benchling Biologics delivers no-code antibody format design and automated registration at scale
validates each entity, including CDR/FR regions, germline gene identification, liability detection, and format-aware validation. The system registers DNA sequences, amino acid sequences, chains, and domains as reusable components linked together. It also generates interactive, color-coded protein glyphs,
More news about: Benchling
May 11, 2026, 07:51 ET ProBio and Curocell Achieve Key CAR-T Milestone with BLA Regulatory Approval and Commercial Readiness
manufacturing of next‑generation therapies. With deep expertise in cell and gene therapy, ProBio delivers integrated, end‑to‑end solutions across mRNA, plasmid DNA, viral vectors, and in vivo CAR‑T therapies.ProBio's scalable, GMP‑compliant platforms support partners from early development through commercial
More news about: ProBio Inc.
May 11, 2026, 06:00 ET Partner Therapeutics Announces FDA Approval of BIZENGRI® (Zenocutuzumab-zbco) for NRG1 Fusion-Positive Cholangiocarcinoma Following Receipt of FDA Commissioner's National Priority Voucher
and NRG1 fusion interactions with HER3, resulting in the suppression of these pathways. Comprehensive molecular testing, notably the combination of tissue-based DNA and RNA next generation sequencing, is essential to identify rare and actionable gene fusions like NRG1.About BIZENGRI (zenocutuzumab-zbco)INDICATIONSBIZENGRI
More news about: Partner Therapeutics, Inc.
May 11, 2026, 03:56 ET Why Next-Gen Devices Demand a New Battery Strategy
second-generation leadership, this is more than a change in management. The family's philosophy of long-term value creation has become part of the company's DNA, carried forward in full through the generational shift. The new generation holds to that core, while bringing a more global perspective, a more structured
More news about: EqualOcean; Guangdong Zhaoneng Technology Co., Ltd. (ZERNE)
May 08, 2026, 16:05 ET Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Authorization
biomarker analysis using a minimally invasive blood sample. Caris Assure uses circulating nucleic acids sequencing (cNAS) to analyze the whole exome (DNA) and whole transcriptome (RNA) of 22,000 genes. This comprehensive test identifies tumor alterations, clonal hematopoiesis (CH) and inherited variants,
More news about: Caris Life Sciences
May 08, 2026, 10:00 ET Duno Health launches the Youth & Vitality Daily Supplement
some inflammatory conditions (2). By combining nicotinamide with key B vitamins, Youth & Vitality aims to promote cellular energy metabolism and DNA repair, and to support health benefits including cardiovascular health, neuroprotection, hormonal and sexual health and anti-aging effects in the skin.
More news about: Duno Health
May 08, 2026, 10:00 ET MDA SPACE INAUGURATES HIGH-VOLUME SATELLITE MANUFACTURING FACILITY IN MONTRÉAL
vision into an achievable mission—bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space